» Articles » PMID: 37985770

Mobilization of Endocannabinoids by Midbrain Dopamine Neurons is Required for the Encoding of Reward Prediction

Overview
Journal Nat Commun
Specialty Biology
Date 2023 Nov 21
PMID 37985770
Authors
Affiliations
Soon will be listed here.
Abstract

Brain levels of the endocannabinoid 2-arachidonoylglycerol (2-AG) shape motivated behavior and nucleus accumbens (NAc) dopamine release. However, it is not clear whether mobilization of 2-AG specifically from midbrain dopamine neurons is necessary for dopaminergic responses to external stimuli predicting forthcoming reward. Here, we use a viral-genetic strategy to prevent the expression of the 2-AG-synthesizing enzyme diacylglycerol lipase α (DGLα) from ventral tegmental area (VTA) dopamine cells in adult mice. We find that DGLα deletion from VTA dopamine neurons prevents depolarization-induced suppression of excitation (DSE), a form of 2-AG-mediated synaptic plasticity, in dopamine neurons. DGLα deletion also decreases effortful, cue-driven reward-seeking but has no effect on non-cued or low-effort operant tasks and other behaviors. Moreover, dopamine recording in the NAc reveals that deletion of DGLα impairs the transfer of accumbal dopamine signaling from a reward to its earliest predictors. These results demonstrate that 2-AG mobilization from VTA dopamine neurons is a necessary step for the generation of dopamine-based predictive associations that are required to direct and energize reward-oriented behavior.

Citing Articles

ABHD6 loss-of-function in mesoaccumbens postsynaptic but not presynaptic neurons prevents diet-induced obesity in male mice.

Lau D, Tobin S, Pribiag H, Nakajima S, Fisette A, Matthys D Nat Commun. 2024; 15(1):10652.

PMID: 39681558 PMC: 11649924. DOI: 10.1038/s41467-024-54819-5.

References
1.
Araque A, Castillo P, Manzoni O, Tonini R . Synaptic functions of endocannabinoid signaling in health and disease. Neuropharmacology. 2017; 124:13-24. PMC: 5662005. DOI: 10.1016/j.neuropharm.2017.06.017. View

2.
Lu H, Mackie K . An Introduction to the Endogenous Cannabinoid System. Biol Psychiatry. 2015; 79(7):516-25. PMC: 4789136. DOI: 10.1016/j.biopsych.2015.07.028. View

3.
Covey D, Hernandez E, Lujan M, Cheer J . Chronic Augmentation of Endocannabinoid Levels Persistently Increases Dopaminergic Encoding of Reward Cost and Motivation. J Neurosci. 2021; 41(32):6946-6953. PMC: 8360683. DOI: 10.1523/JNEUROSCI.0285-21.2021. View

4.
Oleson E, Cheer J . A brain on cannabinoids: the role of dopamine release in reward seeking. Cold Spring Harb Perspect Med. 2012; 2(8). PMC: 3405830. DOI: 10.1101/cshperspect.a012229. View

5.
Lupica C, Riegel A . Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology. 2005; 48(8):1105-16. DOI: 10.1016/j.neuropharm.2005.03.016. View